Pinebridge Investments L.P. Acquires 3,000 Shares of Humana Inc. (NYSE:HUM)

Pinebridge Investments L.P. increased its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 28.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,383 shares of the insurance provider's stock after buying an additional 3,000 shares during the quarter. Pinebridge Investments L.P.'s holdings in Humana were worth $3,395,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently bought and sold shares of the company. Dodge & Cox lifted its position in shares of Humana by 106.7% in the fourth quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after purchasing an additional 5,264,045 shares in the last quarter. Vanguard Group Inc. lifted its position in Humana by 15.8% in the 4th quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after buying an additional 1,751,857 shares in the last quarter. Norges Bank acquired a new stake in shares of Humana during the 4th quarter valued at $416,202,000. Pzena Investment Management LLC grew its holdings in shares of Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock valued at $915,736,000 after acquiring an additional 1,103,132 shares in the last quarter. Finally, Boston Partners increased its stake in shares of Humana by 435.8% in the fourth quarter. Boston Partners now owns 1,098,702 shares of the insurance provider's stock worth $279,236,000 after acquiring an additional 893,637 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HUM. Royal Bank of Canada reaffirmed an "outperform" rating and set a $283.00 price target on shares of Humana in a research note on Wednesday, February 12th. Truist Financial increased their price target on shares of Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a research note on Friday, April 11th. Oppenheimer upped their price objective on shares of Humana from $300.00 to $310.00 and gave the stock an "outperform" rating in a report on Thursday. Raymond James raised Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price target for the company in a research report on Thursday. Finally, Mizuho increased their price objective on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Seventeen analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, Humana currently has an average rating of "Hold" and a consensus target price of $287.76.

Humana Price Performance

HUM stock traded down $3.58 during mid-day trading on Thursday, hitting $258.66. The stock had a trading volume of 475,191 shares, compared to its average volume of 1,751,493. The firm has a fifty day simple moving average of $266.18 and a 200 day simple moving average of $270.70. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The firm has a market capitalization of $31.22 billion, a P/E ratio of 25.99, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating analysts' consensus estimates of $10.07 by $1.51. Humana had a return on equity of 11.70% and a net margin of 1.02%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same period last year, the firm posted $7.23 earnings per share. The business's revenue for the quarter was up 8.4% on a year-over-year basis. As a group, research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.37%. Humana's payout ratio is currently 35.58%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.